LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 308 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $766,000 | +54.7% | 5,026 | +0.9% | 0.01% | +44.4% |
| Q4 2020 | $495,000 | +4.2% | 4,982 | 0.0% | 0.01% | -10.0% |
| Q3 2020 | $475,000 | -14.7% | 4,982 | 0.0% | 0.01% | -23.1% |
| Q2 2020 | $557,000 | +53.9% | 4,982 | 0.0% | 0.01% | +30.0% |
| Q1 2020 | $362,000 | -30.4% | 4,982 | 0.0% | 0.01% | -9.1% |
| Q4 2019 | $520,000 | -4.9% | 4,982 | -9.4% | 0.01% | 0.0% |
| Q3 2019 | $547,000 | -12.9% | 5,500 | 0.0% | 0.01% | -15.4% |
| Q2 2019 | $628,000 | -9.1% | 5,500 | 0.0% | 0.01% | -13.3% |
| Q1 2019 | $691,000 | -48.4% | 5,500 | -22.5% | 0.02% | -6.2% |
| Q4 2018 | $1,338,000 | +80.6% | 7,100 | +163.0% | 0.02% | 0.0% |
| Q3 2018 | $741,000 | – | 2,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |